- April 03, 2024Source: Psychology Today
What I Want My Patients to Know: Ketamine for Depression
- March 25, 2024Source: CNN
Ketamine Therapy on the Rise for Treating Depression, Anxiety
- March 05, 2024Source: Time
The Problem With Our Need to Achieve
- March 05, 2024
Searching Science for Life's Purpose
- January 02, 2024
Duek, Harpaz-Rotem Paper Named '2023 Leading Research Achievement' by BBRF
- December 21, 2023
Holmes Named Recipient of CINP's Rafaelsen Young Investigators Award
Yale Depression Research Program
Operated jointly by the Yale University School of Medicine Department of Psychiatry and Connecticut Mental Health Center, the Yale Depression Research Program has, for over 30 years, been committed to advancing the treatment of depression. By engaging in studies that seek to elucidate the underlying neurobiology of depression, we are striving to improve our ability to diagnose and treat mood disorders.
From the Medical Director
Depression remains one of the most common and debilitating medical problems throughout the world. At the Yale Depression Research Program, we are committed to advancing our ability to understand, diagnose, and treat depression through innovative research.